Sonia L. Betancourt Cuellar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sonia L. Betancourt Cuellar has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo F. Benveniste
Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
5 shared publications Wayne L. Hofstetter
Thoracic & Cardiovasc Surgery Department
5 shared publicationsDiana P. Palacio
Associate Professor, Department of Medical Imaging, The University of Arizona- Banner Medical Center, Tucson, AZ, USA
4 shared publications- Diana Palacio
From the Department of Radiology, Division of Cardiothoracic Imaging, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77550 (A.M., D.M.P.); and Department of Radiology, Division of Cardiothoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, Tex (S.B.C.).
4 shared publications Jeremy J. Erasmus
Diagnostic Radiology, The University of Texas MD Anderson Cancer Center
4 shared publicationsBrett W. Carter
Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
3 shared publications
Latest Publications
- 10 June 2025
- Published by Elsevier in Clinical Imaging
- Vol. 125, 110545
Is 18F-FDG-PET/CT useful in staging of locally advanced signet-ring cell esophageal adenocarcinoma?
- 10 June 2025
- Published by Elsevier in Clinical Imaging
- Vol. 125, 110545
Is 18F-FDG-PET/CT useful in staging of locally advanced signet-ring cell esophageal adenocarcinoma?
- 16 November 2022
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 46 (1) , 25-30
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy
Objective: To determine the incidence and various patterns of radiation-induced liver injury (RILI) and its temporal evolution on fluorodeoxiglucose-positron emission tomography/computed tomography (FDG-PET/CT) after neoadjuvant chemoradiation using precision radiation in patients with esophageal carcinoma. Material and Methods: We evaluated 639 patients with locally advanced esophageal carcinoma who had serial FDG-PET/CTs after neoadjuvant chemoradiation. Two readers reviewed the imaging studies in consensus and recorded the cases where new foci of increased FDG uptake were identified within the radiated liver parenchyma. RILI was confirmed by follow-up imaging or percutaneous biopsy. Results: FDG-avid RILI developed in 39/639 (6%) of patients. The caudate and left hepatic lobe were involved in all cases. There were various patterns of increased FDG uptake: 38% of patients had a single focus of increased FDG uptake and 62% had 2 regions of increased FDG uptake, which were focal nodular or diffuse or a combination of focal nodular and diffuse FDG uptake. On CT, 72% of patients had a poorly-marginated region of low attenuation and 28% had a well-defined region of low attenuation with sharp, well-defined linear borders in the location of the radiation, as confirmed by the treatment plan. Conclusion: The caudate and left hepatic lobes were involved in all cases of RILI. The various imaging patterns of RILI on FDG-PET/CT include 1 or 2 regions of increased FDG uptake with a nodular, diffuse, or combined appearance. Awareness of this potential complication of radiation therapy and knowledge of the imaging manifestations of RILI is important to avoid misinterpretation as a metastasis.
- 16 November 2022
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 46 (1) , 25-30
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy
Objective: To determine the incidence and various patterns of radiation-induced liver injury (RILI) and its temporal evolution on fluorodeoxiglucose-positron emission tomography/computed tomography (FDG-PET/CT) after neoadjuvant chemoradiation using precision radiation in patients with esophageal carcinoma. Material and Methods: We evaluated 639 patients with locally advanced esophageal carcinoma who had serial FDG-PET/CTs after neoadjuvant chemoradiation. Two readers reviewed the imaging studies in consensus and recorded the cases where new foci of increased FDG uptake were identified within the radiated liver parenchyma. RILI was confirmed by follow-up imaging or percutaneous biopsy. Results: FDG-avid RILI developed in 39/639 (6%) of patients. The caudate and left hepatic lobe were involved in all cases. There were various patterns of increased FDG uptake: 38% of patients had a single focus of increased FDG uptake and 62% had 2 regions of increased FDG uptake, which were focal nodular or diffuse or a combination of focal nodular and diffuse FDG uptake. On CT, 72% of patients had a poorly-marginated region of low attenuation and 28% had a well-defined region of low attenuation with sharp, well-defined linear borders in the location of the radiation, as confirmed by the treatment plan. Conclusion: The caudate and left hepatic lobes were involved in all cases of RILI. The various imaging patterns of RILI on FDG-PET/CT include 1 or 2 regions of increased FDG uptake with a nodular, diffuse, or combined appearance. Awareness of this potential complication of radiation therapy and knowledge of the imaging manifestations of RILI is important to avoid misinterpretation as a metastasis.
- 1 December 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (6) , 535-541
Pitfalls and Pearls in Esophageal Carcinoma
- 1 December 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (6) , 535-541
Pitfalls and Pearls in Esophageal Carcinoma
- 8 October 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (4) , 1183-1188
Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients
- 8 October 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (4) , 1183-1188
Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients
- 1 March 2021
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 59 (2) , 219-229
Esophageal Cancer
- 1 March 2021
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 59 (2) , 219-229
Esophageal Cancer
- 1 March 2021
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 59 (2) , 183-192
Thymic Epithelial Neoplasms
- 1 March 2021
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 59 (2) , 183-192
Thymic Epithelial Neoplasms
- Open Access
- 1 July 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 29
Determining extent of invasion and follow-up of thymic epithelial malignancies
Thymic malignancies may exhibit aggressive behavior such as invasion of adjacent structures and involvement of the pleura and pericardium. The role of imaging in the evaluation of primary thymic neoplasms is to properly assess tumor staging, with emphasis on the detection of local invasion and distant spread of disease, correctly identifying candidates for preoperative neoadjuvant therapy. Different imaging modalities are used in the initial investigation of thymic malignancies including chest radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET), in particular with [18F] fluorodeoxyglucose (FDG). At this moment, CT is the most common imaging modality on the assessment of thymic malignancies. MRI has the benefit of no emission of damaging ionizing radiation reducing the radiation dose to the patient when compared with CT. For this reason, MRI has been playing an important role in the evaluation of tumor invasion and follow up imaging studies which becomes even more relevant in young patients or those patients with prior history of radiation therapy.
- 1 July 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 29
Open AccessDetermining extent of invasion and follow-up of thymic epithelial malignancies
Thymic malignancies may exhibit aggressive behavior such as invasion of adjacent structures and involvement of the pleura and pericardium. The role of imaging in the evaluation of primary thymic neoplasms is to properly assess tumor staging, with emphasis on the detection of local invasion and distant spread of disease, correctly identifying candidates for preoperative neoadjuvant therapy. Different imaging modalities are used in the initial investigation of thymic malignancies including chest radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET), in particular with [18F] fluorodeoxyglucose (FDG). At this moment, CT is the most common imaging modality on the assessment of thymic malignancies. MRI has the benefit of no emission of damaging ionizing radiation reducing the radiation dose to the patient when compared with CT. For this reason, MRI has been playing an important role in the evaluation of tumor invasion and follow up imaging studies which becomes even more relevant in young patients or those patients with prior history of radiation therapy.
- 1 March 2019
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 48 (2) , 172-183
Pitfalls and Misinterpretations of Cardiac Findings on PET/CT Imaging: A Careful Look at the Heart in Oncology Patients
- 1 March 2019
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 48 (2) , 172-183
Pitfalls and Misinterpretations of Cardiac Findings on PET/CT Imaging: A Careful Look at the Heart in Oncology Patients
- 1 December 2017
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 38 (6) , 571-583
Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations
- 1 December 2017
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 38 (6) , 571-583
Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations
- 1 December 2017
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 38 (6) , 604-615
Intra- and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors
- 1 December 2017
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 38 (6) , 604-615
Intra- and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors